In a report released today, Erin Wright from Credit Suisse maintained a Buy rating on Idexx Laboratories (NASDAQ: IDXX), with a price target of $259. The company’s shares closed yesterday at $243.26, close to its 52-week high of $252.49.
Wright has an average return of 43.2% when recommending Idexx Laboratories.
According to TipRanks.com, Wright is ranked #587 out of 4847 analysts.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Idexx Laboratories with a $245.50 average price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $252.49 and a one-year low of $146.09. Currently, Idexx Laboratories has an average volume of 427.9K.
Based on the recent corporate insider activity of 52 insiders, corporate insider sentiment is neutral on the stock. Earlier this month, Jacqueline Studer, the CVP, Gen. Counsel & Secretary of IDXX bought 1,785 shares for a total of $141,956.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy and water testing markets. It operates through the following segments: Companion Animal Group; Water; Livestock, Poultry, and Dairy; and Other.
